BIOMAT Database Logo BIOMAT Database Logo

The use of desmopressin (DDAVP) in the preparation of improved factor VIII concentrate. 1984

M Mikaelsson, and I M Nilsson, and B Cedergren, and S Jonsson, and L Rydberg, and B Wiechel

UI MeSH Term Description Entries
D008297 Male Males
D001782 Blood Donors Individuals supplying blood or blood components for transfer to histocompatible recipients. Blood Donor,Donor, Blood,Donors, Blood
D003894 Deamino Arginine Vasopressin A synthetic analog of the pituitary hormone, ARGININE VASOPRESSIN. Its action is mediated by the VASOPRESSIN receptor V2. It has prolonged antidiuretic activity, but little pressor effects. It also modulates levels of circulating FACTOR VIII and VON WILLEBRAND FACTOR. Desmopressin,Vasopressin, Deamino Arginine,1-Deamino-8-D-arginine Vasopressin,1-Desamino-8-arginine Vasopressin,Adiuretin,Adiuretin SD,Apo-Desmopressin,DDAVP,Desmogalen,Desmopressin Acetate,Desmopressin Monoacetate,Desmopressin Monoacetate, Trihydrate,Desmopressine Ferring,Desmospray,Desmotabs,Minirin,Minurin,Nocutil,Octim,Octostim,Acetate, Desmopressin,Arginine Vasopressin, Deamino,Ferring, Desmopressine,Monoacetate, Desmopressin,Monoacetate, Trihydrate Desmopressin,Trihydrate Desmopressin Monoacetate,Vasopressin, 1-Deamino-8-D-arginine,Vasopressin, 1-Desamino-8-arginine
D005169 Factor VIII Factor VIII of blood coagulation. Antihemophilic factor that is part of the factor VIII/von Willebrand factor complex. Factor VIII is produced in the liver and acts in the intrinsic pathway of blood coagulation. It serves as a cofactor in factor X activation and this action is markedly enhanced by small amounts of thrombin. Coagulation Factor VIII,Factor VIII Clotting Antigen,Factor VIII Coagulant Antigen,Factor VIII Procoagulant Activity,Thromboplastinogen,Blood Coagulation Factor VIII,F VIII-C,Factor 8,Factor 8 C,Factor Eight,Factor VIIIC,Hyate-C,Hyatt-C,F VIII C,Hyate C,HyateC,Hyatt C,HyattC
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000941 Antigens Substances that are recognized by the immune system and induce an immune reaction. Antigen
D001127 Arginine Vasopressin The predominant form of mammalian antidiuretic hormone. It is a nonapeptide containing an ARGININE at residue 8 and two disulfide-linked cysteines at residues of 1 and 6. Arg-vasopressin is used to treat DIABETES INSIPIDUS or to improve vasomotor tone and BLOOD PRESSURE. Argipressin,Vasopressin, Arginine,Arg-Vasopressin,Argipressin Tannate,Arg Vasopressin
D014841 von Willebrand Factor A high-molecular-weight plasma protein, produced by endothelial cells and megakaryocytes, that is part of the factor VIII/von Willebrand factor complex. The von Willebrand factor has receptors for collagen, platelets, and ristocetin activity as well as the immunologically distinct antigenic determinants. It functions in adhesion of platelets to collagen and hemostatic plug formation. The prolonged bleeding time in VON WILLEBRAND DISEASES is due to the deficiency of this factor. Factor VIII-Related Antigen,Factor VIIIR-Ag,Factor VIIIR-RCo,Plasma Factor VIII Complex,Ristocetin Cofactor,Ristocetin-Willebrand Factor,von Willebrand Protein,Factor VIII Related Antigen,Factor VIIIR Ag,Factor VIIIR RCo,Ristocetin Willebrand Factor

Related Publications

M Mikaelsson, and I M Nilsson, and B Cedergren, and S Jonsson, and L Rydberg, and B Wiechel
Desmopressin (DDAVP) and factor VIII.
September 2003, Journal of thrombosis and haemostasis : JTH,
M Mikaelsson, and I M Nilsson, and B Cedergren, and S Jonsson, and L Rydberg, and B Wiechel
Use of desmopressin (DDAVP) during early pregnancy in factor VIII-deficient women.
April 2005, Blood,
M Mikaelsson, and I M Nilsson, and B Cedergren, and S Jonsson, and L Rydberg, and B Wiechel
DDAVP, cryoprecipitate, and highly 'purified' factor VIII concentrate in uremia.
January 1986, Nephron,
M Mikaelsson, and I M Nilsson, and B Cedergren, and S Jonsson, and L Rydberg, and B Wiechel
Circumcision in a combined factor V and factor VIII deficiency using desmopressin (DDAVP).
January 2002, The Turkish journal of pediatrics,
M Mikaelsson, and I M Nilsson, and B Cedergren, and S Jonsson, and L Rydberg, and B Wiechel
Circumcision in a combined factor V and factor VIII deficiency using desmopressin (DDAVP).
January 2003, The Turkish journal of pediatrics,
M Mikaelsson, and I M Nilsson, and B Cedergren, and S Jonsson, and L Rydberg, and B Wiechel
Desmopressin (DDAVP) and factor VIII: the tale as viewed from Milan (and Malmö).
April 2003, Journal of thrombosis and haemostasis : JTH,
M Mikaelsson, and I M Nilsson, and B Cedergren, and S Jonsson, and L Rydberg, and B Wiechel
[Subcutaneous injection of desmopressin (DDAVP) for increasing factor VIII and von Willebrand factor in plasmapheresis].
January 1990, Beitrage zur Infusionstherapie = Contributions to infusion therapy,
M Mikaelsson, and I M Nilsson, and B Cedergren, and S Jonsson, and L Rydberg, and B Wiechel
[A new human factor VIII concentrate. Preparation and clinical use].
January 1981, Medicina,
M Mikaelsson, and I M Nilsson, and B Cedergren, and S Jonsson, and L Rydberg, and B Wiechel
Improved factor VIII concentrate of intermediate purity.
May 1977, British journal of haematology,
M Mikaelsson, and I M Nilsson, and B Cedergren, and S Jonsson, and L Rydberg, and B Wiechel
Use of frozen cryoprecipitate for the preparation of clinical factor VIII concentrate.
January 1973, Transfusion,
Copied contents to your clipboard!